Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Control Release ; 347: 561-589, 2022 07.
Article in English | MEDLINE | ID: covidwho-2249019

ABSTRACT

Dissolvable transdermal microneedles (µND) are promising micro-devices used to transport a wide selection of active compounds into the skin. To provide an effective therapeutic outcome, µNDs must pierce the human stratum corneum (~10 to 20 µm), without rupturing or bending during penetration, then release their cargo at the predetermined area and time. The ability of dissolvable µND arrays/patches to sufficiently pierce the skin is a crucial requirement, which depends on the material composition, µND geometry and fabrication techniques. This comprehensive review not only provides contemporary knowledge on the µND design approaches, but also the materials science facilitating these delivery systems and the opportunities these advanced materials can provide to enhance clinical outcomes.


Subject(s)
Needles , Polymers , Administration, Cutaneous , Drug Delivery Systems/methods , Humans , Microinjections/methods , Polymers/pharmacology , Skin
2.
Drug Deliv Transl Res ; 12(11): 2581-2588, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-1739444

ABSTRACT

The triumphant success of mRNA vaccines is a testimony to the important role drug delivery technologies have played in protecting billions of people against SARS-CoV-2 (or the Corona Virus Disease 2019; COVID-19). Several lipid nanoparticle (LNP) mRNA vaccines were developed and have been instrumental in preventing the disease by boosting the immune system against the pathogen, SARS-CoV-2. These vaccines have been built on decades of scientific research in drug delivery of mRNA, vaccines, and other biologicals. In this manuscript, several leading and emerging scientists in the field of drug delivery share their perspective on the role of drug delivery technologies in developing safe and efficacious vaccines, in a roundtable discussion. The authors also discussed their viewpoint on the current challenges, and the key research questions that should drive this important area of research.


Subject(s)
COVID-19 , Nanoparticles , Viral Vaccines , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Liposomes , RNA, Messenger , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL